NuCana PLC (NCNA)
1.55
+0.01
(+0.65%)
USD |
NASDAQ |
Nov 04, 16:00
1.64
+0.09
(+5.81%)
After-Hours: 20:00
NuCana Shareholders Equity (Quarterly): 4.806M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.806M |
| March 31, 2024 | 12.79M |
| December 31, 2023 | 18.96M |
| September 30, 2023 | 26.57M |
| June 30, 2023 | 34.54M |
| March 31, 2023 | 39.33M |
| December 31, 2022 | 46.60M |
| September 30, 2022 | 58.84M |
| June 30, 2022 | 67.96M |
| March 31, 2022 | 77.13M |
| December 31, 2021 | 88.47M |
| September 30, 2021 | 103.99M |
| June 30, 2021 | 116.52M |
| March 31, 2021 | 125.71M |
| December 31, 2020 | 135.23M |
| Date | Value |
|---|---|
| September 30, 2020 | 141.85M |
| June 30, 2020 | 70.32M |
| March 31, 2020 | 74.76M |
| December 31, 2019 | 83.29M |
| September 30, 2019 | 86.30M |
| June 30, 2019 | 92.54M |
| March 31, 2019 | 99.97M |
| December 31, 2018 | 103.53M |
| September 30, 2018 | 110.58M |
| June 30, 2018 | 113.36M |
| March 31, 2018 | 122.56M |
| December 31, 2017 | 126.25M |
| June 30, 2017 | 27.82M |
| December 31, 2016 | 31.01M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.806M
Minimum
Jun 2024
141.85M
Maximum
Sep 2020
69.88M
Average
70.32M
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 96.27M |
| Biodexa Pharmaceuticals PLC | 11.04M |
| Verona Pharma PLC | 168.27M |
| Autolus Therapeutics PLC | 527.84M |
| Mereo BioPharma Group PLC | 78.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.38M |
| Total Liabilities (Quarterly) | 20.58M |